VTX
Vertex Minerals - to Raise up to a$5.1M at a$0.17 per Share
时间:2024-12-24 07:44:54 市场: 综合
Avalo Therapeutics Inc : Btig Initiates Coverage With Buy Rating; Target Price $40
时间:2024-12-19 19:49:27 市场: 美股 综合
LAVA Therapeutics Nv : Leerink Partners Cuts to Market Perform From Outperform; Cuts Target Price to $2 From $11
时间:2024-12-12 20:06:23 市场: 美股 综合
LAVA Reports Third Quarter 2024 Financial Results and Announces Pipeline Reprioritization and Cash Runway Extension Into 2027
时间:2024-12-10 20:30:01 市场: 美股 综合
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
时间:2024-11-14 06:00:00 市场: 综合 美股
Vertex Minerals Ltd-Progress Update at High-Grade Reward Gold Mine
时间:2024-11-13 09:06:53 市场: 综合
Travere Therapeutics: Entered Amended & Restated Agreement of Upto $100 Mln in Common Stock Offering
时间:2024-10-31 20:54:47 市场: 美股 综合
Travere Therapeutics Inc: Interim Data From Spartacus Study Demonstrated That Filspari, When Added to Stable Sglt2i, Was Generally Well Tolerated
时间:2024-10-26 19:01:51 市场: 美股 综合
Avalo Therapeutics, Inc. : H.c. Wainwright Initiates Coverage With Neutral Rating
时间:2024-10-24 18:04:01 市场: 美股 综合
CSL Vifor and Travere Therapeutics Announce Swissmedic Approval of Filspari® (Sparsentan) for the Treatment of Iga Nephropathy
时间:2024-10-17 14:30:03 市场: 美股 综合